Aethlon Medical Inc. (AEMD)
NASDAQ: AEMD
· Real-Time Price · USD
1.76
-0.21 (-10.66%)
At close: Jun 13, 2025, 3:59 PM
1.78
1.14%
After-hours: Jun 13, 2025, 05:54 PM EDT
Aethlon Medical Revenue Breakdown
| Period Ending | Mar 31, 2022 | Mar 31, 2021 |
|---|---|---|
| Govt Contract And Grant Revenue Revenue | 294.17K | 659.1K |
| Govt Contract And Grant Revenue Revenue Growth | -55.37% | n/a |
Revenue by Geography
| Period Ending | Mar 31, 2014 |
|---|---|
| Milestonetwopointthreepointtwopointtwoothermember Revenue | 195.58K |
| Milestonetwopointthreepointtwopointtwoothermember Revenue Growth | n/a |
| Milestone M3 Revenue | 195.58K |
| Milestone M3 Revenue Growth | n/a |
| Milestone M5 Revenue | 208.78K |
| Milestone M5 Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 1.81M | 2.9M | 2.62M | 2.49M | 2.69M | 3.17M | 3.41M | 2.36M | 2.85M | 3.67M | 2.91M | 3.8M | 2.54M | 2.14M | 2.23M | 2.3M | 2.6M | 1.77M | 1.41M | 1.99M | 1.29M | 1.7M | 1.6M | 1.67M | 1.96M | 1.35M | 1.25M | 1.21M | 1.24M | 1.24M | 1.16M | 1.5M | 1.24M | 2.61M | 1.14M | 1.29M | 1.39M | 1.31M | 1.28M | 1.33M |
| Selling, General, and Administrative Revenue Growth | -37.46% | +10.72% | +5.43% | -7.72% | -15.15% | -6.84% | +44.65% | -17.33% | -22.24% | +26.12% | -23.51% | +49.27% | +18.87% | -3.99% | -3.00% | -11.47% | +46.64% | +25.57% | -29.20% | +54.42% | -24.22% | +6.65% | -4.49% | -14.92% | +45.81% | +8.02% | +2.72% | -1.97% | +0.18% | +6.57% | -22.87% | +21.73% | -52.73% | +130.11% | -12.01% | -6.79% | +5.48% | +2.42% | -3.68% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | 644.89K | 593.4K | 628.45K | 678.92K | 615.62K | 558.22K | 852.46K | 858.35K | 937.11K | 354.57K | 478.2K | 587.69K | 704.67K | 461.18K | 508.9K | 377.17K | 234.98K | 218.57K | 222.86K | 248.87K | 240.24K | 243.84K | 178.8K | 194.78K | 123.36K | 129.21K | 168.57K | 157.46K | 175.93K | 178.44K | 280.86K | 117.66K | 205.81K | 147.8K | 207.68K | 182K | 280.34K |
| Research and Development Revenue Growth | n/a | n/a | -100.00% | +8.68% | -5.58% | -7.43% | +10.28% | +10.28% | -34.52% | -0.69% | -8.40% | +164.29% | -25.85% | -18.63% | -16.60% | +52.80% | -9.38% | +34.93% | +60.51% | +7.51% | -1.92% | -10.45% | +3.59% | -1.48% | +36.38% | -8.21% | +57.90% | -4.52% | -23.35% | +7.05% | -10.49% | -1.41% | -36.47% | +138.70% | -42.83% | +39.25% | -28.83% | +14.11% | -35.08% | n/a |